Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is to diagnose PCOS with just hyperandrogenism and irregular periods, and treat with lifestyle changes and basic medications.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Most women with excess hair growth need only a clinical evaluation and minimal tests unless they show signs of virilism.

SHBG may be a useful early indicator and treatment target for PCOS.

Sex hormones may be linked to inflammation in Hidradenitis Suppurativa.

Personalized treatment is crucial for women with hyperandrogenism-related acne and hirsutism.

Some parents have a mild form of congenital adrenal hyperplasia without symptoms, and they usually don't need treatment.

Idiopathic hirsutism is the most common cause of hirsutism in women, followed by PCOS.

Hyperandrogenism in women often causes acne and excess hair, treatable with personalized plans including weight loss, hair removal, and medications.

The document concludes that using LC-MS/MS for measuring androgens is more accurate than older methods, but it needs careful validation and standardized references to be most effective.

Anastrozole can cause increased testosterone, leading to symptoms like hair growth and thinning.

The document concludes that accurate measurement of serum androgens is crucial for diagnosing hyperandrogenism.

A rare ovarian tumor can occur without causing male-like symptoms.

Genetic variants in CYP genes may worsen PCOS symptoms.

A patient with HAIR-AN syndrome, PCOS, and Hashimoto's thyroiditis improved with early diagnosis and treatment to prevent serious health problems.

Male children's genital development issues can be caused by genetic mutations or environmental factors affecting hormone action.

A rare ovarian tumor caused high testosterone, hair loss, and missed periods, but surgery fixed these issues and led to pregnancy.

Hormone imbalances from the pituitary, thyroid, and adrenal glands can cause infertility, but treating these disorders can improve fertility.

Gender-affirming hormone therapy changes hair growth in transgender people, with feminizing therapy reducing hair and masculinizing therapy increasing it, but sometimes additional treatment is needed.

Women with only irregular periods or excess hair have a better hormone profile than those with full PCOS, but both groups are similar, indicating a need for better PCOS diagnosis methods.

Low SHBG and high FAI, FT, and DHEAS levels are effective in identifying PCOS.

Primary hypothyroidism can mimic pituitary failure but improves with hormone therapy.

Certain brain hormones and chemicals are linked to the development of Polycystic Ovary Syndrome.

Some men with early hair loss may have a condition similar to PCOS in women.

The conclusion is that oral contraceptives and antiandrogens can treat hirsutism and acne in women with cutaneous hyperandrogenism, but more research is needed for effective treatments, especially for hair loss.

Almost 40% of Greek women with acne show signs of androgen-related disorders, with adult women more likely affected.

High androgen levels in postmenopausal women may suggest an ovarian tumor, and removing it can improve heart and metabolic health.

Most women with hirsutism or androgenic alopecia had polycystic ovaries, especially if they had irregular periods.

Reducing granulosa cell pyroptosis may improve oocyte maturation in PCOS.

Mohamed Kandil suggests renaming Polycystic Ovary Syndrome to "Polyfollicular Anovulatory Androgenic Syndrome" to better describe its symptoms, but concerns exist that it may not cover all related issues like obesity and depression.